Baillie Gifford & Co Portfolio holdings
Baillie Gifford & Co., founded in 1908 by Lt Col Augustus Baillie and Carlyle Gifford and headquartered in Edinburgh, Scotland, is an independent, partnership-owned investment management firm renowned for its long-term, growth-oriented approach, managing over £230 billion ($290 billion USD) in assets as of late 2024. Focusing primarily on global equities, the firm serves institutional clients like pension funds and retail investors through mutual funds and investment trusts, such as the Scottish Mortgage Investment Trust, emphasizing fundamental research into innovative, high-growth companies—often holding stakes in firms like Tesla and Amazon for decades. With around 2,000 employees across offices in London, New York, Hong Kong, and beyond, Baillie Gifford operates without external ownership pressures, allowing its 58 partners to prioritize patience and conviction over short-term market trends. Known for its low-profile culture and ESG integration, the firm has earned a reputation as a thoughtful, contrarian investor in a world of rapid-fire trading.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pinduoduo
PDD
|
+$382M |
| 2 |
Alibaba
BABA
|
+$272M |
| 3 |
EOG Resources
EOG
|
+$255M |
| 4 |
Broadridge
BR
|
+$234M |
| 5 |
Teladoc Health
TDOC
|
+$189M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$568M |
| 2 |
Royal Caribbean
RCL
|
+$562M |
| 3 |
DATA
Tableau Software, Inc.
DATA
|
+$296M |
| 4 |
MarketAxess Holdings
MKTX
|
+$172M |
| 5 |
APA Corp
APA
|
+$135M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 32.71% |
| 2 | Healthcare | 17.24% |
| 3 | Communication Services | 15.14% |
| 4 | Technology | 11.53% |
| 5 | Financials | 10.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Zai Lab
ZLAB
$2.07B
| $101M | 0.12% |
3,136,100
+1,049,717
| +50% | +$36M |
|
|
ATVI
102
DELISTED
Activision Blizzard
ATVI
| $101M | 0.11% |
1,909,363
+9,874
| +0.5% | +$492K |
|
|
RDFN
103
DELISTED
Redfin
RDFN
| $99.2M | 0.11% |
5,891,270
+111,754
| +2% | +$1.97M |
|
104
Chewy
CHWY
$9.84B
| $97.4M | 0.11% |
3,963,007
+632,321
| +19% | +$19.9M |
|
|
PLAN
105
DELISTED
Anaplan, Inc.
PLAN
| $88M | 0.1% |
1,871,644
| – | – |
|
|
SFIX
106
Stitch Fix
SFIX
$550M
| $86.3M | 0.1% |
4,482,859
-5,387
| -0.1% | -$125K |
|
|
NEWR
107
DELISTED
New Relic, Inc.
NEWR
| $76.1M | 0.09% |
1,238,848
-20,975
| -2% | -$1.52M |
|
108
MakeMyTrip
MMYT
$5.76B
| $72.8M | 0.08% |
3,206,722
-22,926
| -0.7% | -$563K |
|
|
JMIA
109
Jumia Technologies
JMIA
$727M
| $71.4M | 0.08% |
9,007,098
+4,740
| +0.1% | +$73.5K |
|
110
Fastenal
FAST
$57.4B
| $70.3M | 0.08% |
4,301,754
+224,980
| +6% | +$3.5M |
|
111
Coca-Cola
KO
$374B
| $62.8M | 0.07% |
1,154,288
+60,318
| +6% | +$3.23M |
|
112
C.H. Robinson
CHRW
$17.9B
| $61.8M | 0.07% |
728,596
+29,664
| +4% | +$2.49M |
|
113
Petrobras Class A
PBR.A
$105B
| $60.5M | 0.07% |
4,602,439
-292,160
| -6% | -$3.9M |
|
114
Sea Limited
SE
$70.4B
| $60.3M | 0.07% |
1,949,414
-1,478,932
| -43% | -$49.7M |
|
115
Procter & Gamble
PG
$342B
| $60.2M | 0.07% |
484,210
+16,999
| +4% | +$2.01M |
|
|
ONC
116
BeOne Medicines Ltd
ONC
$34B
| $59.9M | 0.07% |
488,894
+390,370
| +396% | +$51.9M |
|
|
BZUN
117
Baozun
BZUN
$172M
| $57.3M | 0.07% |
1,341,996
+20,892
| +2% | +$993K |
|
|
EXAS
118
DELISTED
Exact Sciences
EXAS
| $55.8M | 0.06% |
616,970
-94,462
| -13% | -$10.8M |
|
|
EB
119
DELISTED
Eventbrite
EB
| $52.2M | 0.06% |
2,948,267
+13,736
| +0.5% | +$241K |
|
120
Moderna
MRNA
$22.5B
| $51.2M | 0.06% |
3,214,797
+7,202
| +0.2% | +$106K |
|
121
PepsiCo
PEP
$189B
| $49.8M | 0.06% |
363,137
+15,579
| +4% | +$2.07M |
|
122
STAAR Surgical
STAA
$1.14B
| $49.2M | 0.06% |
1,908,288
+130,666
| +7% | +$3.97M |
|
|
IRBT
123
DELISTED
iRobot
IRBT
| $47.1M | 0.05% |
764,234
+18,003
| +2% | +$1.29M |
|
124
Codexis
CDXS
$156M
| $44.9M | 0.05% |
3,271,100
+68,276
| +2% | +$1.07M |
|
125
Pacira BioSciences
PCRX
$979M
| $43.8M | 0.05% |
1,151,710
+156,871
| +16% | +$6.26M |
|
Similar funds
Baillie Gifford & Co's Q3 2019 Portfolio in Review
As of Q3 2019, Baillie Gifford & Co held 235 positions worth $87.9B, down 6.7% from $94.3B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Baillie Gifford & Co's Q3 2019 filing shows 9 new, 87 increased, 97 reduced and 10 closed positions. Its largest new stake was Peloton Interactive: 6,848,821 shares worth $172M. The largest sale was Baidu, an estimated $568M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Communication Services.
- Baillie Gifford & Co's largest Q3 2019 buy was Peloton Interactive: 6,848,821 shares worth $172M.
- Baillie Gifford & Co added most to Pinduoduo in Q3 2019, an estimated $382M increase.
- Baillie Gifford & Co's biggest Q3 2019 reduction was Baidu, cutting an estimated $568M.
- Baillie Gifford & Co fully exited Royal Caribbean in Q3 2019, selling an estimated $562M.
- Baillie Gifford & Co's ten largest holdings make up 44% of its $87.9B portfolio in Q3 2019.
- Baillie Gifford & Co opened 9 new positions and closed 10 in Q3 2019.
- Baillie Gifford & Co's portfolio value fell 6.7% quarter-over-quarter to $87.9B.
Based on Baillie Gifford & Co's 13F filing for Q3 2019, filed 7 Nov 2019.